Blogs

CA125: The Silent Signal—Detecting Ovarian Cancer before It Speaks

Cancer Antigen 125 (CA-125) is a glycoprotein biomarker used in the medical field for the detection and management of ovarian cancer. CA-125 is found in higher concentrations in the blood of women with ovarian cancer; its applications extend beyond cancer detection, as high levels may also be found in various non-cancerous conditions.

Clinical Significance of CA-125

CA-125 plays an important role in diagnosing and managing diseases, including:

1. Ovarian Cancer Detection: Screening and Diagnosis with Monitored Treatment.
2. Non-Ovarian Cancers: Elevated CA-125 levels are not exclusive to ovarian cancer. They are also observed in other malignancies, e.g., fallopian tube, endometrial, pancreatic, breast, and other colorectal cancers. In these cases, CA-125 is used more as a secondary marker for assessing the extent of disease or treatment effectiveness.
3. Non-Cancerous Conditions:

• Endometriosis: It is a condition in which tissue similar to the uterine lining grows outside the uterus, which raises the level of CA125.
• Pelvic Inflammatory Disease (PID): This infection can also raise the level of CA125.
• Menstruation
• Pregnancy: During pregnancy, the CA-125 level rises in the first trimester.
• Liver diseases like Cirrhosis raise the level of CA125.

Different Diagnostic ways to test for CA-125 level

The most common method for assessing CA-125 levels is a blood test.

Commonly used methods to detect CA-125 levels in laboratories include electrochemiluminescence (ECLIA), Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA) and Radioimmunoassay (RIA).

The detection ofCA-125 based on the most advanced Chemiluminescence Immunoassay is used for quantitative measurement of Cancer Antigen 125 (CA125) in human serum/plasma as an aid in treatment monitoring of ovarian cancer.

Conclusion CA125 , a tumour marker, is primarily associated with epithelial ovarian cancer. While elevated levels of CA125 can indicate the presence of malignancy, particularly in postmenopausal women, higher levels are also observed in various benign conditions such as menstruation, endometriosis, pelvic inflammatory disease, and pregnancy. Therefore, in patients with confirmed ovarian cancer, CA125 is particularly useful for monitoring treatment response and detecting recurrence. Diagnosing CA125 levels through blood tests helps healthcare providers understand the underlying causes of ovarian cancer and develop appropriate treatment plans..

Explore the Product…

CA125 iClia

Advantages of Chemiluminescence in HIV, HCV, and HBsAg Testing

HIV, HCV, and HBsAg (HHH) detection in blood banks before transfusion is important for disease control, timely diagnosis, and prevention of their transmission, as these 3 markers are highly infectious. Chemiluminescence immunoassay CLIA have superior sensitivity, high specificity & rapid turnaround times compared to ELISA or radioimmunoassay. CLIA technology also facilitates accurate detection of analytes at very low concentrations, enhancing its performance in minimising false results and improving diagnostic accuracy. Additionally, its compatibility with automation and high-throughput testing makes chemiluminescence highly stable for regular clinical laboratories and blood screening.

Clinical Significance of Chemiluminescence in HHH range and Interpretation

1. CLIA have excellent sensitivity for detecting both low and high concentrations of analytes in HIV, HCV & HBsAg, making it highly suitable for early diagnosis.
2. Due to its low detection limits, CLIA can accurately identify very small amounts of analytes, which is important for detecting low-level HBsAg in clinical samples.
3. Chemiluminescence technology plays a crucial role in infectious disease diagnosis in Blood banks to ensure safe blood transfusion and patient safety.
4. CLIA tests for HIV and HBsAg screening are fourth-generation tests, as they detect both HIV antigens (p24) and antibodies and have better analytical sensitivity for HBsAg, thereby improving detection in early infection.

Interpretation of chemiluminescence results in HHH range:

The result interpretation is based on the sample-to-cutoff ratio (S/CO) in LIA. Since these are sensitive tests, borderline reactive samples should be carefully reanalysed through repeat testing and correlated with clinical symptoms and other diagnostic investigations for highly accurate & clinical interpretation.

Different diagnostic tests for HIV, HCV, and HBsAg (HHH)

Commonly used methods to detect HIV, HCV, and HBsAg in blood banks include electrochemiluminescence (ECLIA), Chemiluminescence Immunoassay (CLIA) & Enzyme-Linked Immunosorbent Assay (ELISA).

The 4th generation HIV chemiluminescence immunoassay, designed for the qualitative detection of antibodies to HIV-1 and HIV-2 and HIV-1 p24 antigen ,HBsAg CLIA for Hepatitis B surface antigen (HBsAg) and HCV CLIA for HCV Antibody detection is primarily used as a screening test for blood donors before transfusion to ensure blood safety.

Conclusion:

In conclusion, CLIA offers significant advantages over traditional ELISA and rapid tests for HIV, HCV & HBsAg screening, especially in terms of sensitivity, speed & automation in high-volume settings. CLIA utilises a luminescent molecule to emit light, providing an absolute measurement that results in superior analytical performance. CLIA also provides a wide linear range, allowing for precise detection of HHH markers compared to the limited absorbance range of ELISA. These methods also elevate workflow efficiency and decrease diagnostic errors, thereby ensuring safe blood transfusion in Blood banks and better patient management in Laboratories.

Explore the Product…

HIV Ag & Ab iClia

HBsAg iClia

HCV iClia

High-Sensitivity Troponin I: Variability Within the Normal Range and Clinical Implications

Troponin I (hs-TnI) is a key cardiac biomarker used for the prompt identification and diagnosis of myocardial injury. Troponin I, a protein involved in regulating cardiac muscle contraction, is released into the bloodstream when heart muscle cells are damaged.

Clinical Significance of High-Sensitivity Troponin I lies in its role in diagnosing and managing diseases, including:

• Elevated hs-TnI is associated with a worse prognosis in chronic heart failure, chronic kidney disease, and diabetes.
• May indicate ongoing subclinical myocardial injury.
• May help rule out myocardial infarction in chest pain of non-cardiac origin.
• Elevated hs-TnI may be observed in sepsis, pulmonary embolism, stroke, and COVID-19.

Different Diagnostic ways to test for hs–Troponin–I levels

Commonly used methods to detect hs-Troponin-I levels in laboratories include electrochemiluminescence (ECLIA), Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), and fluorescence-based immunoassay methods (FIA). The detection of hs-Troponin-I, based on a Chemiluminescence Immunoassay, is used for quantitative measurement of hs-Troponin-I levels in human serum/plasma as an aid in the diagnosis of Myocardial Infarction.

Conclusion Highly Sensitive Troponin I is a valuable cardiac biomarker for accurately detecting myocardial injury, including minor myocardial damage.  Increased hs-TnI levels are commonly detected in more severe cases and are closely linked to higher rates of complications, including myocarditis, arrhythmias, heart failure, and overall mortality. Its high sensitivity is useful for early risk assessment and treatment planning.

Explore the Product…

hs-Troponin-I iClia

D-Dimer:  Biomarker for Diagnosis of Thrombotic Disorders

Introduction

D-dimer is a protein fragment formed when cross-linked fibrin is broken down by plasmin during fibrinolysis. It is present in very low concentrations in the bloodstream. Under normal physiological conditions, clot formation and destruction remain balanced, preventing excess bleeding and ensuring proper blood flow after blood vessel healing.

Elevated D-dimer levels are found in disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), and pulmonary embolism (PE). Other circumstances, such as old age, pregnancy, cancer, liver disease, and infection, may also lead to high D-dimer levels. The ELISA system has higher sensitivity than latex agglutination tests, providing improved aid in the diagnosis and exclusion of venous thromboembolism (VTE).

Clinical Significance of D-Dimer

D-dimer plays an essential role in diagnosing, managing, and monitoring several medical conditions involving thrombosis and coagulation disorders.

1. Diagnosis of Venous Thromboembolism (VTE)

D-dimer testing is extensively used to rule out venous thromboembolism, including:

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)

2. Disseminated Intravascular Coagulation (DIC)

D-dimer concentrations increase significantly in patients with DIC due to widespread activation of coagulation and fibrinolysis. It is an important laboratory marker included in DIC diagnostic scoring systems.

3. Cardiovascular Diseases

Elevated D-dimer levels have been found in Patients diagnosed with cardiovascular disorders, including acute coronary syndrome, ischemic stroke, peripheral arterial disease, and atrial fibrillation.

4. COVID-19 and Critical illness

During COVID-19 pandemic, D-dimer was recognised as a valuable prognostic marker . Elevated D-dimer levels were frequently associated with severe disease, thromboembolic complications, the need for intensive care, and an increased risk of mortality. Consequently, D-dimer testing became an integral part of clinical assessment, helping clinicians monitor disease progression and identify patients at greater risk of adverse outcomes.

5. Other Clinical Applications

Elevated D-dimer levels are also observed in malignancies, pregnancy, liver disease, trauma, major surgery, sepsis, and advanced age.

Different Methods for D-Dimer Diagnosis

Doctors recommend D-dimer testing to measure D-dimer levels in serum or plasma. Normal D-dimer levels vary depending on factors such as the individual’s age and sex. For a healthy human body, the reference range is generally less than 500 ng/mL (nanograms per millilitre) or less than 0.50 mg/L (milligrams per litre).

Conclusion

D-dimer is a vital biomarker for evaluating thrombotic and fibrinolytic activity in patients with suspected coagulation disorders. Elevated D-dimer levels are not specific for any single disease; they provide critical diagnostic and prognostic information when interpreted in conjunction with clinical assessment and imaging studies. Various laboratory methods—including ELISA, latex agglutination, immunoturbidimetric assays, fluorescence immunoassays, and CLIA—are available for D-dimer estimation, each with different advantages and limitations. The chemiluminescence-based tests are a better diagnostic approach due to higher accuracy and excellent reproducibility. The advancement of CLIA-based diagnostic platforms is expected to enhance the clinical utility of D-dimer testing further and improve patient outcomes across a broad range of medical specialities.

Explore the Product…

D-Dimer iClia

Beyond Diet: The Truth About Celiac Disease

Introduction

Celiac disease occurs in individuals as a reaction to gluten sensitivity. Gluten is a protein that is found in various cereals like Wheat, Barley, and rye. If a patient with celiac disease consumes food containing gluten, this will lead to damage to the mucous membrane of the small intestine.

Tissue transglutaminase (tTG) is an enzyme that is released from cells during inflammation. Measurement of serum anti-tissue transglutaminase (tTG) antibodies is the most common serological test used in screening for celiac disease. To treat celiac disease, doctors advise patients to eat gluten-free food.

Clinical Significance of anti-tTG and Interpretation

Celiac disease has significant clinical importance because it can affect multiple organ systems. If left undiagnosed or untreated, celiac disease may lead to serious complications such as malnutrition, anaemia, osteoporosis, neurological disorders, growth retardation and an increased risk of some intestinal malignancies. Early identification of disease and associated risk factors plays a crucial role in timely diagnosis, disease prevention, and long-term patient management.

The interpretation of genetic and risk-factor analysis in celiac disease requires careful clinical correlation with serological tests, symptoms, and the person’s diet.

Different Diagnostic ways to test for anti-tTG IgA antibody levels

A doctor recommends an anti-tTG IgA antibody test to check for Celiac Disease.

Commonly used methods to detect Anti-tTG IgA antibody levels in laboratories include electrochemiluminescence (ECLIA), immunoturbidimetric method, Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA) and Fluorescent Enzyme Immunoassay (FEIA).

The detection of anti-tTG IgA Antibodies is based on the most advanced Chemiluminescence Immunoassay. It is used for qualitative detection of anti-tTG IgA antibodies in Human Serum or Plasma samples as an aid in recognition and diagnosis of Celiac disease.

Conclusion

Celiac Disease is an autoimmune disorder that is affected by factors such as family history, gluten exposure, infections, and other autoimmune conditions, which contribute to Celiac disease development and progression. Ultimately, Early identification of the disease plays a crucial role in timely diagnosis, disease prevention, and long-term patient management. The interpretation of genetic and risk-factor analysis in celiac disease requires careful clinical correlation with serological tests, symptoms, and the person’s diet.

Explore the Product…

Celiac iClia

Progesterone: The hormone that ensures balance, harmony, and a healthy pregnancy

Progesterone is an essential hormone that regulates multiple biological processes in the female reproductive system. It is produced primarily in the ovaries, adrenal glands, and placenta during pregnancy. Progesterone has an essential function in preparing the endometrium layer of the uterus for Implantation. In addition to its fertility functions, progesterone influences other bodily systems, such as the brain and cardiovascular health.

Clinical Significance of Progesterone and Interpretation:

Progesterone plays a vital role in conditions including:

• Maintenance of the uterus during pregnancy.
• Treatment of secondary amenorrhea and endometrial hyperplasia.
• Marker for fertility; low levels lead to lowered fertility.
• To monitor conditions like ectopic pregnancy (a condition in which a fertilised egg implants other than the uterus, such as the fallopian tube), miscarriage, and cancers like adrenal and Ovarian.
• To monitor PCOS – polycystic ovarian syndrome, as progesterone levels become higher in the presence of Cysts.
• To determine the cause of abnormal bleeding in the uterus.

Diagnostic methods available for testing progesterone levels:

A doctor recommends a progesterone test to measure progesterone levels in the blood. Commonly used methods for detecting progesterone levels in laboratories include: Chemiluminescence Immunoassay (CLIA), chromatographic techniques such as High-Performance Liquid Chromatography (HPLC), Radioimmunoassay (RIA), Enzyme-Linked Immunosorbent Assay (ELISA), and Progesterone Receptor Assay.

The detection of Progesterone based on the most advanced chemiluminescence immunoassay is used for quantitative measurement of Progesterone level in human serum/plasma samples as an aid in the diagnosis of threatened abortion in conjunction with other laboratory and clinical findings.

Conclusion Progesterone  plays a vital role in regulating many body functions, particularly in women. It helps regulate the menstrual cycle, supports a healthy pregnancy, and contributes to overall hormonal balance. When progesterone levels become too low or too high, they can disrupt normal body functions and lead to a range of health concerns.

Explore the Product…

Progesterone iClia

CK-MB: An Important Cardiac Biomarker for the Diagnosis of Heart Muscle Damage

CK-MB is a cardiac marker for the diagnosis of myocardial infarction and myocarditis. It is a creatine kinase enzyme composed of muscle and brain subunits and can be used to assess tissue injury. When the myocardium experiences structural injury or oxygen deprivation, it releases CK-MB directly into the bloodstream. Previously, CK-MB was considered the standard for diagnosing a heart attack; however, now HS Troponin I is considered the gold standard. CK-MB plays a crucial role in some cases, such as detecting Reinfarction. It helps diagnose even minor irritations as well as severe complications. In people with advanced kidney disease, doctors sometimes use CK-MB to get a clear timeline of acute events.

Clinical Significance of CK-MB and Interpretation:

Abnormal CK-MB levels are clinically important in diagnosing and managing several conditions, including:

• Acute Myocardial infarction: CK-MB levels rise approximately 3-6 hours after myocardial infarction, peak in 12-24 hours and return to normal within 48-72 hours.
• Reinfarction: . When chest pain accompanies elevated CK levels/ CK-MB along with chest pain ,it often indicates a recent heart attack. If CK-MB levels initially rise and then fall, followed by another increase, this may suggest a second heart attack or ongoing heart damage.
• Monitoring Post–Heart Procedures: It helps detect even minor irritations and severe complications after angioplasty, stent placement, and CABG (Coronary artery bypass graft) surgery.

Different Diagnostic Ways to test for CK-MB level:

Doctors recommend a CK-MB test to measure the level of CK-MB in human serum or plasma.

Common laboratory methods for detecting CK-MB levels include Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), and Fluorescence Immunoassay (FIA). CK-MB detection is based on the most commonly used chemiluminescent immunoassay (CLIA) for quantitative measurement in human serum and plasma.

Conclusion

Measuring CK-MB is crucial for diagnosing myocardial infarction, particularly in the case of Acute Myocardial Infarction (AMI) as it is present in heart muscle cells. CK-MB levels typically rise 4-6 hours after a myocardial infarction, peak at around 24 hours, and return to normal within three days. This pattern of elevation and decline, combined with other cardiac markers, ECG changes, and the patient’s chest pain history, has become an essential method for diagnosing acute myocardial infarction.

Explore the Product…

CK-MB iClia

Prostate-Specific Antigen (PSA) – Early Detection, Lifesaving Insights

Prostate-Specific Antigen (PSA) is produced by the prostate gland, located in the male reproductive system. There are two forms of PSA  ; total PSA ( bound to proteins ) and free PSA (freely circulating) . The ratio of free PSA to total PSA ( per cent-free PSA) is usually found to be comparatively low in patients  with prostate cancer compared to those without the condition.

PSA as a Diagnostic Biomarker

The prostate-specific antigen (PSA) test is widely used to evaluate prostate health and plays an important role in detecting prostate cancer. PSA test results provide valuable information in combination with other diagnostic methods, such as imaging scans or a prostate biopsy. PSA testing is also used to monitor whether the cancer has recurred or if the patient is in remission.

Factors That Influence PSA Levels

Age: PSA levels increase slightly with age.

Benign prostatic hyperplasia (BPH): PSA levels may increase in this condition (non-cancerous enlargement of the prostate).

Medical Procedures: Medical procedures, such as prostate biopsies or catheterisation, can raise PSA levels temporarily.

Different Diagnostic Ways to test for PSA level

• Measurement of PSA levels in the blood sample to screen for prostate cancer.
• Serum PSA Level – Most men have PSA levels under 4 ng/mL, which means they are not affected by prostate cancer.
• Commonly used methods to detect PSA Levels in laboratories include Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Magnetic Resonance Imaging, Prostate-Specific Risk Stratification Bioassays, and fluorescent immunoassay.
• The detection of PSA using the most advanced Chemiluminescence Immunoassay is used for quantitative measurement of Prostate-specific antigen (t-PSA) in human serum/plasma, and for monitoring in clinical observation, prognosis, and recurrence monitoring of prostate cancer.

Conclusion:  PSA levels are important for both patients and healthcare providers to make informed decisions. Monitoring of PSA tests, especially for men at higher risk for prostate cancer, can ensure that individuals take a proactive approach to their prostate health.

Explore the Product…

t-PSA iClia

Understanding Ferritin: Your Body’s Iron Storage Solution

Ferritin is a protein widely distributed in all living organisms, including bacteria, algae, higher plants, animals, and humans. Ferritin stores iron in our cells, which indirectly measures the amount of iron in our body. Iron is essential for healthy red blood cells, muscles, bone marrow, and organs.

Clinical Significance of Ferritin and Interpretation

Its clinical significance lies in its role in diagnosing and managing diseases, including:

• Hemochromatosis- having too much iron in your body, which is also called iron overload.

• Iron deficiency, also called anemia, is a condition in which your body has too few red blood cells.

• Liver diseases, which include cirrhosis, in which a considerable amount of the ferritin is stored in the liver.

Restless leg syndrome is a tingling or burning feeling in your legs that may be caused by a lack of iron.

• AOSD, also called adult-onset Still disease, is an uncommon disease that causes joint pain, fever, arthritis, and rash, with high ferritin levels.

• Tracking chronic conditions that may affect your levels of iron, such as cancer, kidney disease, and autoimmune diseases.

• Hemophagocytic syndrome, also known as macrophage activation syndrome or lymph histiocytic syndrome, is a heterogeneous group of disorders with a final common pathway consisting of hypertriglyceridemia, hyperferritinemia, pancytopenia, and multiple organ failure, which is highly fatal.

• Parkinson’s disease is also linked to abnormalities in ferritin level.

Different Diagnostic ways to test for Ferritin level

A doctor may recommend a ferritin test to measure ferritin levels in the blood.

Serum Ferritin Level – Normal range for Ferritin level in men is 24 to 336 micrograms per liter, and in women is 11 to 307 micrograms per liter.

Commonly used methods to detect Ferritin Level in laboratories include electrochemiluminescence (ECLIA), immunoturbidimetric method, Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), and Radioimmunoassay (RIA).

The detection of Ferritin using the most advanced Chemiluminescence Immunoassay enables quantitative measurement of Ferritin levels in human serum/plasma samples, aiding in monitoring the recurrence and metastasis of malignant tumors.

Conclusion

The ferritin test is an important diagnostic tool for assessing iron stores in the body. It is used to evaluate iron levels present in the human body. Higher ferritin levels can indicate inflammation in the body, while low ferritin levels indicate iron deficiency in human beings. Overall, the serum ferritin test is the most commonly used method for measuring ferritin levels, offering a simple, reliable way to assess iron status.pecificity require careful understanding in interpretation ,in combination with other diagnostic tools and clinical factors. It also results in enhanced cancer care by providing more accurate, non-invasive, and personalized treatment options.

Explore the Product…

Ferritin iClia

CA-125: The blood test that helps you stays one step ahead of ovarian cancer!

Cancer Antigen 125 (CA-125) is a glycoprotein biomarker & used in the medical field for the detection and management of ovarian cancer, also known as the carbohydrate antigen 125. CA-125 is a cell surface glycoprotein which is found in higher concentrations in the blood of women having ovarian cancer. Its applications extend beyond cancer detection, as its levels can also be elevated in various non-cancerous conditions.

Clinical Uses of CA-125

1. Ovarian Cancer Detection:
   • Screening and Diagnosis:
   • Monitoring Treatment and Recurrence:
2. Non-Ovarian Cancers:
   • Elevated CA-125 levels are not exclusive to ovarian cancer. They also observed in other malignancies, e.g., fallopian tube, endometrial, pancreatic, breast, and other colorectal cancers. In these cases, CA-125 is used more as a secondary marker for assessing the extent of disease or treatment effectiveness.
3. Non-Cancerous Conditions:
   • Endometriosis:
   • Pelvic Inflammatory Disease (PID):
   • Fibroids:
   • Menstruation:
   • Pregnancy
   •  Liver diseases
   • Kidney disease
4. Risk Assessment and Prognosis:

Diagnosis Markers and Tests used for Cancer Antigen 125 (CA-125)  

• HE4 (Human Epididymis Protein 4):
• Transvaginal Ultrasound (TVUS):
• CT Scans and MRIs
• Future Directions and Research
• Blood Test (Serum CA-125 Test)
• Pelvic Examination
• Biopsy
• Genetic Testing (e.g., BRCA1 and BRCA2)

Limitations of CA-125 Testing

• False Positives: Many non-cancerous conditions can cause elevated CA-125 levels, potentially leading to false positives. For example, menstruation, pregnancy, and other benign gynecological conditions can all raise CA-125 levels.
• False Negatives: Not all ovarian cancers produce elevated CA-125 levels, particularly in early-stage disease, which limits the sensitivity of this test. For example, in women with early-stage ovarian cancer or those with non-epithelial ovarian cancers, CA-125 levels may not be significantly raised.
• Lack of Specificity: CA-125 levels are most often associated with ovarian cancer, but other malignancies and various benign conditions can also elevate CA-125. This lack of specificity means CA-125 should not be used in isolation to diagnose cancer or assess treatment effectiveness without considering other clinical factors and imaging tests.

Conclusion

It aids in the management of ovarian cancer detection and monitoring purposes. It is an essential part of clinical practice. The constraints in sensitivity and specificity require careful understanding in interpretation ,in combination with other diagnostic tools and clinical factors. It also results in enhanced cancer care by providing more accurate, non-invasive, and personalized treatment options.

Explore the Product…

CA125 iClia

AFP: Your Early Warning System for Tumors!

AFP is a glycoprotein found in high concentrations in the blood of a developing fetus. It plays a pivotal role in managing the growth and development of the fetus. After birth, AFP levels drop significantly and remain low throughout adulthood.

Key Uses of the AFP Test:

1. Liver Cancer (Hepatocellular Carcinoma – HCC): AFP is commonly elevated in individuals with liver cancer, especially in those with chronic hepatitis or cirrhosis.
2. Testicular Cancer: AFP can be elevated in non-seminomatous testicular cancers, such as yolk sac tumors.
3. Ovarian Cancer: Certain ovarian cancers, especially those of the germ cell type, may produce AFP.
4. Monitoring Treatment Response: In patients with known AFP-producing tumors, the test helps monitor treatment effectiveness and detect recurrence.
5. Screening for Fetal Abnormalities (in Pregnancy): AFP levels are part of the triple or quadruple screening tests to evaluate and assess the risk of probable circumstances like neural tube defects or Down syndrome  in the fetus.

Defining AFP Test Results

Normal AFP Levels:

• Adults: Generally less than 10 ng/mL (can vary by lab).
• Pregnant Women: Levels vary with gestational age and are higher than in non-pregnant individuals.

Elevated AFP Levels May Indicate:

• Liver cancer
• Germ cell tumors (testicular, ovarian)
• Liver diseases (cirrhosis, hepatitis)
• Pregnancy-related conditions (if abnormal)
• Certain rare cancers (e.g., stomach, pancreatic)

Low AFP Levels:

• Less commonly, a concern, but very low levels may be seen in some types of testicular cancer or other conditions.

What Affects AFP Results?

• Non-cancer conditions: Liver disease, hepatitis, and cirrhosis can raise AFP levels.
• Pregnancy: AFP levels are naturally higher during Pregnancy, especially in the second trimester.
• Age and Gender: Normal ranges can vary slightly based on lab standards.

Limitations of the AFP Test

• Non-Specific: Elevated AFP is not definitive for cancer and may occur in benign conditions.
• False Positives/Negatives: Some cancers do not make AFP, and not all situations of elevated AFP would be cancerous.

Conclusion The AFP Tumor Marker Test is a invaluable tool in oncology and hepatology, helping in the early detection . It also supports management of certain cancers and liver conditions. However, it should always be interpreted in the context of clinical findings, history, and other diagnostic tests. If you have concerns about AFP levels, consult a healthcare provider for personalized advice.

Explore the Product…

AFP iClia

FSH: The Primary Effector in Hormone Unlocking Reproductive Health

Follicle-stimulating hormone (FSH), a member of the gonadotropin hormone group, plays a vital role in reproductive function for both males and females. It affects and acts on granulosa cells in the ovaries of females and Sertoli cells in the testes of males. In females, it supports the maturation and ovulation of eggs each month, while in males, it aids in sperm production.

Role of FSH

• FSH stimulates sperm production and works together with testosterone, which is triggered by LH, to maintain continuous sperm production within the testes in males.
• FSH plays a fundamental role in governing the menstrual cycle by catalyzing the growth of ovarian follicles. It also helps in preparing eggs for ovulation in females.

Clinical Significance of Follicle Stimulating Hormone and Interpretation

      Its clinical significance lies in its role in diagnosing and managing diseases, including:

• Polycystic Ovarian Syndrome – Elevated FSH levels can indicate ovarian dysfunction, which may be linked to conditions like menopause or polycystic ovary syndrome (PCOS).
• Hypothalamic dysfunction: Low levels of FSH can indicate issues such as hypothalamic dysfunction or excessive body fat in conditions like obesity.
• Male Fertility: Low FSH levels may affect sperm production. Elevated FSH levels may be a sign of testicular dysfunction, such as in cases of Klinefelter syndrome or testicular failure.
• Hypogonadotropic Hypogonadism: Lower-than-normal FSH levels can result in incomplete puberty development. In adults, this can cause impaired ovarian or testicular function, often leading to infertility. This condition is known as hypogonadotropic hypogonadism.
• Premature ovarian failure: It occurs before age 40. When this happens, FSH levels are elevated. Turner Syndrome is the most common disorder causing premature ovarian failure.

Different Diagnostic ways to test for FSH level

FSH test through urine is a qualitative test. This may help indicate if you are in menopause or perimenopause. A doctor recommends the FSH test to measure the level of FSH in the blood.

Commonly used methods to detect FSH levels in laboratories include Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), and Radio-immunoassay(RIA).

FSH iClia is a chemiluminescent microparticle immunoassay (AE-based) used for the quantitative determination of Follicle Stimulating Hormone (FSH) in Human serum and plasma.

Conclusion Follicle-stimulating hormone (FSH) plays an important and crucial role in regulating reproductive health, influencing the development of eggs in females and sperm development in males. Abnormal FSH levels can be indicative of various conditions, such as or example ovarian insufficiency, menopause,  or fertility issues. Diagnosing FSH levels through blood tests and urine tests helps healthcare providers understand the underlying causes of reproductive dysfunction and develop appropriate treatment plans. Timely and accurate diagnosis of FSH imbalances is essential for addressing fertility concerns and managing hormonal health effectively.

Explore the Product…

FSH iClia